Cargando…

Development of a new Japanese version of the Clinical Impairment Assessment Questionnaire

BACKGROUND: The Clinical Impairment Assessment questionnaire (CIA) is used to measure the severity of psychosocial impairment in patients with eating disorders. The purpose of the present study was to develop a new Japanese version of the CIA (CIA-J) and to evaluate its reliability and validity. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Horie, Takeshi, Hiraide, Maiko, Takakura, Shu, Hata, Tomokazu, Sudo, Nobuyuki, Yoshiuchi, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457750/
https://www.ncbi.nlm.nih.gov/pubmed/32884580
http://dx.doi.org/10.1186/s13030-020-00194-8
_version_ 1783576059215609856
author Horie, Takeshi
Hiraide, Maiko
Takakura, Shu
Hata, Tomokazu
Sudo, Nobuyuki
Yoshiuchi, Kazuhiro
author_facet Horie, Takeshi
Hiraide, Maiko
Takakura, Shu
Hata, Tomokazu
Sudo, Nobuyuki
Yoshiuchi, Kazuhiro
author_sort Horie, Takeshi
collection PubMed
description BACKGROUND: The Clinical Impairment Assessment questionnaire (CIA) is used to measure the severity of psychosocial impairment in patients with eating disorders. The purpose of the present study was to develop a new Japanese version of the CIA (CIA-J) and to evaluate its reliability and validity. METHODS: We translated the sixteen items of the CIA into Japanese, back-translated them into English, and had them verified by a native English speaking professional editor. Participants were 152 Japanese-speaking patients (30.4 ± 10.6 years) under treatment for eating disorders and 173 healthy controls (29.5 ± 8.3 years). In addition to the CIA-J, the participants were asked to answer the Eating Attitudes Test (EAT26), The Positive and Negative Affect Schedule (PANAS), and the Hospital Anxiety and Depression Scale (HADS). We performed confirmatory factor analyses to evaluate the factor structure, calculated the Cronbach’s alphas of the CIA-J to assess the reliability, and calculated the correlation coefficients between the CIA-J score and those of EAT26, PANAS, and HADS to assess concurrent validity. We also used a Kruskal-Wallis test followed by Steel-Dwass test to compare the scores of the subtypes of eating disorders and the healthy control group. RESULTS: A three-factor structure was obtained, similar to the original version. The Cronbach’s alphas of both the global and subscale scores of the CIA-J were high. The CIA-J had significant positive correlations with the EAT26, the negative affect subscale of the PANAS, and the HADS. The global and subscale scores for all subtypes of eating disorders were significantly higher than those of the healthy control group. CONCLUSIONS: The CIA-J was determined to be reliable and valid for assessing the severity of psychosocial impairment in patients with eating disorders.
format Online
Article
Text
id pubmed-7457750
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74577502020-09-02 Development of a new Japanese version of the Clinical Impairment Assessment Questionnaire Horie, Takeshi Hiraide, Maiko Takakura, Shu Hata, Tomokazu Sudo, Nobuyuki Yoshiuchi, Kazuhiro Biopsychosoc Med Research BACKGROUND: The Clinical Impairment Assessment questionnaire (CIA) is used to measure the severity of psychosocial impairment in patients with eating disorders. The purpose of the present study was to develop a new Japanese version of the CIA (CIA-J) and to evaluate its reliability and validity. METHODS: We translated the sixteen items of the CIA into Japanese, back-translated them into English, and had them verified by a native English speaking professional editor. Participants were 152 Japanese-speaking patients (30.4 ± 10.6 years) under treatment for eating disorders and 173 healthy controls (29.5 ± 8.3 years). In addition to the CIA-J, the participants were asked to answer the Eating Attitudes Test (EAT26), The Positive and Negative Affect Schedule (PANAS), and the Hospital Anxiety and Depression Scale (HADS). We performed confirmatory factor analyses to evaluate the factor structure, calculated the Cronbach’s alphas of the CIA-J to assess the reliability, and calculated the correlation coefficients between the CIA-J score and those of EAT26, PANAS, and HADS to assess concurrent validity. We also used a Kruskal-Wallis test followed by Steel-Dwass test to compare the scores of the subtypes of eating disorders and the healthy control group. RESULTS: A three-factor structure was obtained, similar to the original version. The Cronbach’s alphas of both the global and subscale scores of the CIA-J were high. The CIA-J had significant positive correlations with the EAT26, the negative affect subscale of the PANAS, and the HADS. The global and subscale scores for all subtypes of eating disorders were significantly higher than those of the healthy control group. CONCLUSIONS: The CIA-J was determined to be reliable and valid for assessing the severity of psychosocial impairment in patients with eating disorders. BioMed Central 2020-08-31 /pmc/articles/PMC7457750/ /pubmed/32884580 http://dx.doi.org/10.1186/s13030-020-00194-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Horie, Takeshi
Hiraide, Maiko
Takakura, Shu
Hata, Tomokazu
Sudo, Nobuyuki
Yoshiuchi, Kazuhiro
Development of a new Japanese version of the Clinical Impairment Assessment Questionnaire
title Development of a new Japanese version of the Clinical Impairment Assessment Questionnaire
title_full Development of a new Japanese version of the Clinical Impairment Assessment Questionnaire
title_fullStr Development of a new Japanese version of the Clinical Impairment Assessment Questionnaire
title_full_unstemmed Development of a new Japanese version of the Clinical Impairment Assessment Questionnaire
title_short Development of a new Japanese version of the Clinical Impairment Assessment Questionnaire
title_sort development of a new japanese version of the clinical impairment assessment questionnaire
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457750/
https://www.ncbi.nlm.nih.gov/pubmed/32884580
http://dx.doi.org/10.1186/s13030-020-00194-8
work_keys_str_mv AT horietakeshi developmentofanewjapaneseversionoftheclinicalimpairmentassessmentquestionnaire
AT hiraidemaiko developmentofanewjapaneseversionoftheclinicalimpairmentassessmentquestionnaire
AT takakurashu developmentofanewjapaneseversionoftheclinicalimpairmentassessmentquestionnaire
AT hatatomokazu developmentofanewjapaneseversionoftheclinicalimpairmentassessmentquestionnaire
AT sudonobuyuki developmentofanewjapaneseversionoftheclinicalimpairmentassessmentquestionnaire
AT yoshiuchikazuhiro developmentofanewjapaneseversionoftheclinicalimpairmentassessmentquestionnaire